The global biotech API manufacturing services market, valued at US$ 38.9 Bn in 2022, is anticipated to grow at a CAGR of 7.1% and exceed US$ 73 Bn by 2031. Factors such as increasing demand for ...

Importantly, this is accomplished without contacting or impeding the manufacturing process. The result is material cost savings for API customers due to improved manufacturing process control ...

Over the past several months, manufacturers pushed technological limits to release products to optimize API and drug product manufacturing processes. Some of these technologies include advancements in ...

A typical API manufacturing process involves use of highly corrosive chemicals such as concentrated acids which places considerable demands on both the filter housing and the filter cartridges used.

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.

Macsen Labs Group announces the commencement of construction of its new Active Pharmaceutical Ingredient (API) manufacturing facility near one of its existing units, Macsen Drugs in RIICO ...